@ISGDtweets
Account based inUnited States!
About this account
- Account based in
- United States
- Connected via
- United States App Store
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
A professional society for glomerular disease experts, founded 2022. President @Tobias_B_Huber Español @ISGD_la 🦋 https://nitter.cf/t.co/uXHF9301vy
Massachusetts/worldwide
Joined August 2022
- Tweets2K
- Following923
- Followers2.4K
- Likes2.3K
Don't Wait. Submit Now.
Late-Breaking Abstracts Open Through October 1.
🌊 Your research belongs in Galveston!
The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts!
📅 Opens Sept. 1
⏰ Deadline Oct. 1
Share your latest research with leaders in glomerular disease.
🔬 Submit: CTS 2026 Late Breaker Info
@Barbara58932871 @Tobias_B_Huber @ISGDtweets
🚀 The future of pediatric clinical trials starts here!
ISGD Pediatric Clinical Trials Bootcamp is coming to ESPN 2026. Practical training, mentorship & networking to prepare the next generation of trial investigators.
👉 Register now! congressespn.org/ipna-espn-j…
#ISGD #ESPN2026 #ClinicalTrials
International Society of Glomerular Disease retweeted
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… @NEJM @fervenzaf
International Society of Glomerular Disease retweeted
Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS. @h4amer @NDTsocial
dx.doi.org/10.1093/ndt/gfag1…
academic.oup.com/ndt/article…
ISGD meets in Philadelphia.A meaningful visit to the Hospital of the University of Pennsylvania brought together colleagues, clinical perspectives, and important conversations about the future of glomerular medicine.Connecting. Learning. Advancing. Together.
@Barb @Tobi @ISGD
#ISGD #GlomerularMedicine #GlomerularDisease #Nephrology #KidneyResearch
Six more experts. Six more perspectives. One big goal. 🔬 Meet more of the incredible speakers joining the ISGD Clinical Trials Summit in Galveston, Nov. 13–15! 🌎 Clinical trials. Collaboration. The future of glomerular medicine. 👉 is-gd.org/2026-CTS
🌊 Your research belongs in Galveston!
The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts!
📅 Opens Sept. 1
⏰ Deadline Oct. 1
Share your latest research with leaders in glomerular disease.
🔬 Submit: CTS 2026 Late Breaker Info
@Barbara58932871 @Tobias_B_Huber @ISGDtweets
🤖 Made with AI
International Society of Glomerular Disease retweeted
Measuring slit diaphragm autoantibodies could transform care by distinguishing low-risk from high-risk autoimmune podocytopathies, improving prognosis, treatment selection, and transplant planning, according to new study in #ASNJASN. kidney.pub/JASN1195
Missed the 15th International Podocyte Conference 2025 in Hamburg? 👀 @PodocyteIPC
We've got you covered.
Dive into this fresh review highlighting the latest advances, emerging concepts, and evolving landscape of podocyte and glomerular disease research as discussed by the scientific community 🌍🔬🧬
👉 Catch up on what’s shaping the field.
#PodocyteConference
@Tobias_B_Huber @ISGD_la
kidney-international.org/act…
International Society of Glomerular Disease retweeted
Moving forward by building networks and joining forces across stakeholders. Together, let’s solve kidney disease—disease by disease—and shift the equilibrium from kidney disease to kidney health. @ISGDtweets @nephcure
SEISMIC: A multi-stakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN - Kidney International kidney-international.org/art…
👀 And the list goes on…with STILL more to come!! 🚀
Meet some of the experts shaping the inaugural #ISGD Clinical Trials Summit:
Myda Khalid | Brendon Neuen | Alessia Fornoni | Abigail Smith | Laura Barisoni
📍 Galveston | Nov 13–15
👉 is-gd.org/2026-cts
🤖 Made with AI
International Society of Glomerular Disease retweeted
A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy
@mvargas07 @AnilaCara @fervenzaf @LadanZand @GlassockJ @andreaangioi @SethiRenalPath
kidney-international.org/art…
🌎 ISGD welcomes 4 new Board leaders!
🔬 Kretzler — translational research
🧪 Rovin — clinical trials
👧 Vivarelli — pediatric nephrology
💜 Lightstone — lupus nephritis & patient advocacy
👉 Read more: is-gd.org/en/news-from-isgd/…
The future of kidney disease treatment depends on trial-ready investigators and sites.
ISGD’s Clinical Trials BootCamps are helping build that future—equipping the next generation of investigators with practical tools, mentorship, networking, and a pathway into clinical research.
Featured in the August issue of ASN Kidney News.
As the program expands globally—and now into adult nephrology—we’re building capacity where it is needed most.
Why ISGD? Why Now?
Read the article: kidneynews.org/view/journals…
#ISGD #ClinicalTrials #Nephrology #KidneyResearch
✨ Only 100 days until the inaugural 2026 ISGD Clinical Trials Summit! We’re spotlighting our outstanding Program Advisory Committee, whose expertise is shaping an exciting, forward-thinking program. Join us in Galveston Nov 13-15, 2026! 🌎 🧬
Register Now: is-gd.org/2026-cts @Tobias_B_Huber @Barbara58932871
🤖 Made with AI
International Society of Glomerular Disease retweeted
Our new article Multi-omics of kidney biopsies in ANCA-associated GN:
🔹 Complement activation precedes visible glomerular injury
🔹 Monocytes dominate the infiltrate
🔹 Novel TRIM21/25 axis + noncanonical IFN signaling
🔹 PD-L1 checkpoint failure
doi.org/10.1002/acr2.90114
🚨 The countdown is on! August 1 is your last chance to save with early registration and submit your abstract for the inaugural ISGD Clinical Trials Summit, hosted by UTMB. Recently presented work is welcome! Join us Nov. 13–15 in Galveston, TX. 🌍🧬 #ISGD #ClinicalTrials
🔗 Register: is-gd.org/2026-cts
➤ Submit your abstract: is-gd.org/cts-2026-abstract-…
@Tobias_B_Huber @Barbara58932871 @JochenReiser @gupta__vineet @SWadhwaniMD
🤖 Made with AI
International Society of Glomerular Disease retweeted
Our #IWG @ERAkidney work on disease modification in lupus nephritis has just been published in #NRN
nature.com/articles/s41581-0…
@IoannisParodis @Lupusreference @smirioglu @LuvacsL @AnnetteBruchfe1 @StefanieSteige6 @sarah_m_moran @OhioStateNeph @KateIsabelle24 et al.
🚨 August 1 is almost here! Register early and submit your abstract for the 2026 ISGD Clinical Trials Summit hosted by UTMB. Join leading experts in glomerular disease Nov. 13–15 in Galveston, TX.
➤ Register today: is-gd.org/2026-cts
➤ Submit Abstracts: is-gd.org/cts-2026-abstract-…
Be sure to check out UTMB Office of Innovation and Commercialization post to see even more of the expert speakers joining us this November!
#ISGD #ClinicalTrials #Nephrology @Tobias_B_Huber @Barbara58932871 @JochenReiser @gupta__vineet @SWadhwaniMD
🤖 Made with AI
